Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
Enrolling by invitation · NCT07228325 · Registry updated 2025-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis | Hypersensitivity, Immediate, allergic disease, anaphylaxis, immune system disorder | Enrolling by invitation | Phase 1 / Phase 2 | 2025-11-14 | NCT07228325 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nasus Pharma | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pharma Medica Research Inc | Mississauga | Canada | 1 |